Potent, selective peptidomimetic thrombin inhibitors emerge from U.S.-Canadian partnership April 8, 1999
Novartis identifies thrombin inhibitors with improved pharmacodynamic and pharmacokinetic properties April 7, 1999
Temporary platelet inhibition by SM-20302 results in sustained antithrombotic efficacy in dog model April 1, 1999
RSS